eTFDS 4-2017 net - Side 25



(11) Slawomirski L. Use of PROM in OECD member states. 17-2-2017.
(12) Gelkopf M, Pagorek-Eshel S, Trauer T, Roe D. Routine outcome measurement in mental health service consumers: who
should provide support for the self-assessments? Eval Program Plann 2015 Jun;50:43-6.
(13) Roe D, Gelkopf M, Gornemann MI, Baloush-Kleinman V, Shadmi E. Implementing routine outcome measurement in psychiatric rehabilitation services in Israel. Int Rev Psychiatry 2015;27(4):345-53.
(14) Roe D, Lapid L, Baloush-Kleinman V, Garber-Epstein P, Gornemann MI, Gelkopf M. Using Routine Outcome Measures to
Provide Feedback at the Service Agency Level. Community Ment Health J 2016 Nov;52(8):1022-32.
(15) Roe D, Werbeloff N, Gelkopf M. Do persons with severe mental illness who consume the psychiatric rehabilitation basket of services in Israel have better outcomes than those who do not? Isr J Psychiatry Relat Sci 2010;47(3):166-70.
(16) Psychiatry – Aalborg University Hospital. Behandlingskvaliteten for patienter med depression henholdsvis skizofreni belyst ved hjælp af patientrapporterede oplysninger; Et anvendelsesorienteret udviklings- og forskningsprojekt (Programmet i Sundhedstjenesteforskning). Programmet i Sundhedstjensteforskning . 2017.
(17) Valderas JM, Kotzeva A, Espallargues M, Guyatt G, Ferrans CE, Halyard MY, et al. The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature. Qual Life Res 2008 Mar;17(2):179-93.
(18) Kendrick T, El-Gohary M, Stuart B, Gilbody S, Churchill R, Aiken L, et al. Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults. Cochrane Database Syst Rev 2016
Jul 13;7:CD011119.
(19) Carter N, Klein R, Day P. How organisations measure success. The use of performance indicators in government. p. 49.
London, UK: Routledge; 1995.
(20) The Food and Drug Administration (FDA) (2009). Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Avaliable from http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf [Last accessed 22.02.2017]. U S Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Center for
Devices and Radiological Health (CDRH) 2009 Dec;1-43.
(21) Members of the High Level Reflection Group of OECD. RECOMMENDATIONS TO OECD MINISTERS OF HEALTH FROM THE
HIGH LEVEL REFLECTION GROUP ON THE FUTURE OF HEALTH STATISTICS – Strengthening the international comparison
of health system performance through patient-reported indicators. Avaliable from https://www.oecd.org/els/healthsystems/Recommendations-from-high-level-reflection-group-on-the-future-of-health-statistics.pdf [Last accessed
04.03.2017]. Paris: OECD; 2017.
S U N D H E D S V Æ S E N E T L I G E N U · TFDS 4–2017
25

Paperturn



Powered by


Fuld skærm Klik for at læse
Paperturn bladre katalog system
Søg
Oversigt
Download som PDF
Fuld skærm
Afslut fuld skærm
Luk
Luk
Paperturn
Emailen er nu afsendt.
Dette felt skal udfyldes
Indtast venligst en gyldig e-mail-adresse
Dette felt skal udfyldes
Indtast venligst en gyldig e-mail-adresse
Paperturn Sender. Vent venligst...
Paperturn
Luk